Due to ongoing geopolitical developments and planned increased tariffs affecting the worldwide trade the costs for the production and distribution of PMMA molding compounds increase. For this reason, the Röhm Group must react to the corresponding tariff increases.

Effective April 1, 2025, Röhm GmbH will increase the prices for its XT® Polymer molding compounds.

• Parallel Fluidics specializes in rapid manufacturing of microfluidics prototypes
• Röhm’s special product CYROLITE® MD offers exceptional transparency and UV transmittance for diagnostic components
• Molding compound with excellent flow behavior and highest reproduction accuracy
  
  

Effective October 1, 2024, Röhm GmbH will increase the prices for its CYROLITE®, CYROLITE® MD and CYREX® acrylic-based products.

Effective March 1, 2024, Röhm GmbH will increase the prices for its CYROLITE®, CYROLITE® MD, CYREX® and Vu-Stat® acrylic-based products.

• The cooperation between Röhm and IMCD, which has existed since 2020, is being extended to Switzerland and Liechtenstein.
  
  

• The Wand - STA Single Tooth Anesthesia® System is a device for computer-controlled local anesthesia as a gentle alternative to injections
• Milestone Scientific has been relying on CYROLITE® molding compounds for components of the disposable handpieces for the past 25 years
• The high-quality medical plastic from Röhm impresses with its resistance to gamma sterilization, permanent transparency and stability

• Röhm will exhibit at MD&M West medical technology trade show February 7-9
• Show will coincide with the launch of two new products: CYROLITE® G-20 CP and CYROLITE® MD zk6

• New facility marks the largest non-production investment in the region
• Enhanced resources reinforce commitment to future of CYROLITE® & ACRYLITE® Molding Compounds innovation

Effective January 1st, 2023, Röhm GmbH will increase the prices for its XT® Polymers compounds for medical device industry.

Effective June 1, 2022, Röhm GmbH will increase the prices for its CYROLITE®, CYROLITE® MD, XT® POLYMER, CYREX® and Vu-Stat® acrylic-based products.

• Becton, Dickinson (BD) manufactures urine meters for urine meter drain bags from CYROLITE® molding compounds from Röhm
• High transparency enables visual inspection of flow and fluid levels
• Medical-grade plastic can be sterilized and is resistant to bodily fluids

The most significant investment of its kind for the Region Americas Molding Compounds business, to be built in Wallingford, Connecticut.

• Enhanced resources reinforce commitment to the future of CYROLITE® & ACRYLITE® Molding Compounds customers – enabling partners to grow with Roehm
• Hiring 8 new Technical Center team associates
• Start of operation planned for second quarter, 2022

• TissueFlow, a medical start-up, develops the BoneFlo®+ operation instrument for pioneering methods in bone surgery
• Röhm offers a proven material for innovative medical technology under the brand CYROLITE®
• CYROLITE® material offers high transparency, gamma stability and precision during injection molding

Effective June 1, 2021, Röhm GmbH will increase the prices for its CYROLITE®, CYROLITE® MD, XT® POLYMER, CYREX® and Vu-Stat® acrylic-based products.

• MediPure™ Adult IV filters from ITW Medical protect patients from bacteria, microparticles and trapped air
• Filter housings made of CYROLITE® can be sterilized and are robust, disinfectants- and pressure-resistant
• ITW Medical is planning to use CYROLITE® CG-97 again for the next generation of filters

• Baumann Dental is relaunching the proven Zentrik-Platten-System (ZPS®) with CYROLITE®
• CYROLITE® medical plastic is biocompatible, resistant to disinfectants and easy to process
• Röhm impresses with material quality, delivery reliability and service

Effective April 1, 2020, IMCD N.V., headquartered in Rotterdam (The Netherlands), will be marketing and distributing Röhm’s entire portfolio of acrylic-based CYROLITE® copolymers and CYROLITE® MD products for the medical device and diagnostics markets in Europe except Switzerland and Liechtenstein.